Quality of Life in Children Cured of Retinoblastoma

NCT00278031 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2016-10-04

No results posted yet for this study

Summary

The aim of the study is to assess the quality of life of children who have been cured of retinoblastoma - a malignant eye tumor. The study is questionnaire-based, and uses standardized quality of life assessment tools.

Conditions

  • Retinoblastoma

Sponsors & Collaborators

  • Israel Cancer Association

    collaborator OTHER
  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Michael Weintraub, MD · Hadassah Medical Organization

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00278031 on ClinicalTrials.gov